Dabigatran and left atrial appendage thrombus

Journal of Thrombosis and Thrombolysis

Volumn 34, Issue 4, 2012, Pages 545-547

  Vidal, Alejandro ^a   Vanerio, Gabriel ^a  

^a CASMU Arrhythmia Service   (Uruguay)

Author keywords

Atrial fibrillation; Dabigatran; Thrombus

Indexed keywords

ANTIVITAMIN K; ATORVASTATIN; DABIGATRAN; DILTIAZEM; LOSARTAN; WARFARIN;

ADULT; ARTICLE; CARDIOVERSION; CASE REPORT; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; LEFT ATRIAL APPENDAGE THROMBUS; PRIORITY JOURNAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ANTITHROMBINS; ATRIAL APPENDAGE; BENZIMIDAZOLES; BETA-ALANINE; FEMALE; HEART DISEASES; HUMANS; MIDDLE AGED; THROMBOSIS; WARFARIN;

EID: 84868201111     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0747-1     Document Type: Article

References (20)

1. Prasad V, Kaplan RM, Passman RS (2012) New frontiers for stroke prevention in atrial fibrillation. Cerebrovasc Dis. 33:199-208
2. Freeman WD, Aguilar MI (2011) Prevention of cardioembolic stroke. Neurotherapeutics 8:488-502
3. Wolfram O, Hammwoehner M, Gramley F, Goette A (2011) Update on pharmacologic approaches to prevent thromboembolism in atrial fibrillation: are thrombin and factor Xa inhibitors the ultimate answer? Curr Vasc Pharmacol 9:350-357
4. Broukhim M, Halperin JL (2011) Stroke prevention in the high-risk atrial fibrillation patient: Medical management. Curr Cardiol Rep. 13:9-17
5. Medi C, Hankey GJ, Freedman SB (2010) Stroke risk and antithrombotic strategies in atrial fibrillation. Stroke 41:2705-2713
6. Santos-Gallego CG, Bayón J, Badimón JJ (2010) Thrombi of different pathologies: implications for diagnosis and treatment. Curr Treat Options Cardiovasc Med. 12:274-291
7. Savelieva I, Bajpai A, Camm AJ (2007) Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices. Ann Med 39:371-391 (Pubitemid 47263436)
8. Thambidorai SK, Murray RD, Parakh K, Shah TK, Black IW, Jasper SE, Li J, Apperson-Hansen C, Asher CR, Grimm RA (2005) ACUTE investigators. utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study). Am J Cardiol 96:935-941 (Pubitemid 41363763)
9. Odum LE, Cochran KA, Aistrope DS, Snella KA (2012) The CHADS(2) versus the new CHA(2) DS(2) -VASc scoring systems for guiding Antithrombotic treatment of patients with Atrial Fibrillation: Review of the Literature and Recommendations for Use. Pharmacotherapy 32:285-296
10. Harenberg J, Leber G, Dempfle CE, Heene DL, Zimmermann R, Kübler W (1989) Long term anticoagulation with low molecular weight heparin in outpatients with side effects on oral anticoagulants. Nouv Rev Fr Hematol 31:363-369 (Pubitemid 19264198)
11. Roijer A, Eskilsson J, Olsson B (2000) Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion. Eur Heart J 21:837-847 (Pubitemid 30240771)
12. Sinnaeve PR, Huang Y, Bogaerts K, Vahanian A, Adgey J, Armstrong PW, Wallentin L, Van de Werf FJ (2006) age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: findings from assessment of the Safety and Efficacy of a new Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS. Am Heart J 152(684):e1-e9
13. Connolly SJ, Ezekowitz MD, Yusuf S, et al., and the RE-LY Steering Committee and Investigators(2009) Dabigatran versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med361:1139-1151
14. Di Nisio M, Middeldorp S, Büller HR (2005) Direct thrombin inhibitors. N Engl J Med 353:1028-1040 (Pubitemid 41262337)
15. Clouse LH, Comp PC (1986) The regulation of hemostasis: The protein C system. N Engl J Med 314:1298
16. Weinreich DJ, Burke JF, Pauletto FJ (1984) Left ventricular mural thrombi complicating acute myocardial infarction. Long-term follow-up with serial echocardiography. Ann Intern Med 100:789-794 (Pubitemid 14121586)
17. Banner DW, Hadvary P (1993) Inhibitor binding to thrombin: X-ray crystallographic studies. Adv Exp Med Biol 340:27-33 (Pubitemid 24052399)
18. Hauptmann J, Sturzebecher J (1999) Synthetic inhibitors of thrombin and factor Xa: from bench to bedside. Thromb Res 93:203-241 (Pubitemid 29130456)
19. Xiao Z, Theroux P (1998) Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circulation 97:251-256 (Pubitemid 28067310)
20. Sarich TC, Wolzt M, Eriksson UG et al (2003) Effects of ximelagatran, an oral direct thrombin inhibitor, r-hirudin and enoxaparin on thrombin generation and platelet activation in healthy male subjects. J Am Coll Cardiol 41:557-564 (Pubitemid 36223319)